ResMed nominates new member of board of directors

ResMed has nominated Carol Burt for an open position on its board of directors, with an election to take place at the firm's annual meeting of stockholders on November 14th 2013.

Ms Burt is a principal of Burt-Hilliard Investments, a private investment and consulting firm to the healthcare industry, and is the former senior vice-president of corporate finance and development for the health benefits company WellPoint.

She has been nominated to fill the board position currently occupied by Michael Quinn, who has been a member for 21 years but has announced he will not be standing for re-election.

Mr Quinn has been credited with helping the company to achieve significant growth on a global scale over the last two decades.

ResMed chief executive officer Michael Farrell said: "Reducing costs associated with treatment of chronic conditions such as hypertension and heart failure is escalating as a priority in care management. With Ms Burt's guidance, we'd like to accelerate that escalation."

Last month, the company announced the completion of enrolment for Serve-HF, the world's largest study of sleep-disordered breathing in heart failure.